imatinib mesylate has been researched along with Eosinophilia, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cogan, E; Roufosse, F | 1 |
| Azuma, T; Fujiwara, H; Suemori, K; Watanabe, S; Yasukawa, M | 1 |
| Bagot, M; Battistella, M; Flageul, B; Galicier, L; Hickman, G; Isvy-Joubert, A; Petit, A | 1 |
| Anastasi, J; Hossain, NM; Jain, N; McConville, JF; Odenike, O; Steinmetz, JL | 1 |
| Akata, S; Aoshima, M; Iwaya, K; Kurakawa, E; Miyazawa, K; Nagate, A; Ohyashiki, K; Serizawa, H; Shimamoto, T; Yokoyama, T | 1 |
| Pardanani, A; Patnaik, MM; Tefferi, A | 1 |
| Peros-Golubicić, T; Smojver-Jezek, S | 1 |
2 review(s) available for imatinib mesylate and Eosinophilia, Pulmonary
| Article | Year |
|---|---|
Eosinophilia: secondary, clonal and idiopathic.
Topics: Benzamides; Bone Marrow; Chromosome Aberrations; Cytokines; Eosinophilia; Gene Rearrangement; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Parasitic Diseases; Piperazines; Protein Kinase Inhibitors; Pulmonary Eosinophilia; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta | 2006 |
Hypereosinophilic syndrome: diagnosis and treatment.
Topics: Antibodies, Monoclonal; Benzamides; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pulmonary Eosinophilia; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2007 |
5 other study(ies) available for imatinib mesylate and Eosinophilia, Pulmonary
| Article | Year |
|---|---|
[Practical approach to hypereosinophilia].
Topics: Benzamides; Eosinophils; Food Hypersensitivity; Glucocorticoids; Hematologic Diseases; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Mutation; Neoplasms; Parasitic Diseases; Piperazines; Prednisone; Protein-Tyrosine Kinases; Pulmonary Eosinophilia; Pyrimidines | 2008 |
A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.
Topics: Aged; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Interstitial; Piperazines; Pulmonary Eosinophilia; Pyrimidines; Radiography; Treatment Outcome | 2010 |
[Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
Topics: Antineoplastic Agents; Benzamides; Biopsy; Bone Marrow; Diagnosis, Differential; Eosinophilia; Humans; Imatinib Mesylate; Male; Middle Aged; mRNA Cleavage and Polyadenylation Factors; Mucous Membrane; Myeloproliferative Disorders; Oncogene Proteins, Fusion; Piperazines; Pulmonary Eosinophilia; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Skin Ulcer | 2012 |
A 32-year-old man with persistent cough, shortness of breath, eosinophilic pneumonia, and peripheral blood eosinophilia. Myeloid neoplasm associated with eosinophilia and platelet-derived growth factor receptor-alpha rearrangement.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow Neoplasms; Cough; Dyspnea; Eosinophilia; Gene Rearrangement; Humans; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pulmonary Eosinophilia; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Steroids; Treatment Outcome | 2012 |
Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pulmonary Alveoli; Pulmonary Eosinophilia; Pulmonary Fibrosis; Pyrimidines | 2004 |